INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
Go back to INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point| (NASDAQ: INMB) | Delayed: 1.46 +0.03 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $ | |||
| Open | $1.39 | 52 Week Low | $ | |||
| Day High | $1.50 | P/E | N/A | |||
| Day Low | $1.39 | EPS | $ | |||
| Volume | 290,349 | |||||

